Therapeutic agent for arteriosclerosis or arteriosclerotic disease, and diagnostic agent for arteriosclerosis or arteriosclerotic disease

摘要

Atherosclerosis and arteriosclerosis are improved by a pharmacological mechanism that reduces arteriosclerotic lesions. A complex in which an antibody that binds to folate receptor β (FRβ) and a cytotoxin or cytotoxic agent are conjugated or the antibody is contained as an active ingredient.